SAGE THERAPEUTICS, I

SAGE
Delayed Quote. Delayed  - 02/26 04:00:01 pm
85USD +1.86%
Upcoming events on SAGE THERAPEUTICS, INC.
03/01/21 | 04:00pm Cowen & Co. Health Care Conference
05/06/21 Q1 2021 Earnings Release (Projected)
08/10/21 Interim 2021 Earnings Release (Projected)
11/04/21 Q3 2021 Earnings Release (Projected)

Past events on SAGE THERAPEUTICS, INC.
02/25/21 | 08:00amSVB Leerink Global Healthcare Conference
02/24/21 | 08:00amFY 2020 Earnings Call
02/24/21FY 2020 Earnings Release
01/12/21 | 10:50amJP Morgan Healthcare Conference

Upcoming sector events for SAGE THERAPEUTICS, INC.
02/26/21 | 04:35pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

Past sector events for SAGE THERAPEUTICS, INC.
02/25/21 | 01:40pmGILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 | 01:40pmEXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
1 114
7,04
15 717%

23,0
Operating income
(EBITDA)
M $
Released
Forecast
Spread
627
-479
231%

-234
Operating profit
(EBIT)
M $
Released
Forecast
Spread
624
-483
229%

-454
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
606
-471
229%

-450
Net income
M $
Released
Forecast
Spread
606
-473
228%

-444
EPS
$
Released
Forecast
Spread
11,4
-9,07
226%

-7,78
Announcement Date02/24/2021


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q42021 Q1 (e)
Sales
M $
Released
Forecast
Spread
1 109
10,1
10 843%

1,91
Operating income
(EBITDA)
M $
Released
Forecast
Spread
974
-113
964%

349
Operating profit
(EBIT)
M $
Released
Forecast
Spread
974
-48,5
2 106%

-113
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
975
-30,8
3 268%

-107
Net income
M $
Released
Forecast
Spread
975
-115
951%

-109
EPS
$
Released
Forecast
Spread
18,2
-1,05
1 828%

-1,94
Announcement Date02/24/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise